|
Market Cap (6-Jul) $277,062,656 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $3.12 |
52w Low $2.13 |
P/E 22.37 |
EPS 0.1 |
AFP released this announcement to the ASX on 1 November 2021, 7:31. The announcement is marked as price sensitive, and is 3 page(s) in length and 166.57kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| US FDA accepts Maxigesic IV New Drug Application | 1 November 2021, 7:31 |
| Maxigesic IV registered in the UK and Ireland | 19 October 2021, 9:03 |
| half year interim results announcement 18 Nov 2021 | 12 October 2021, 7:31 |
| AFT further extends Maxigesic footprint strengthens EU | 21 September 2021, 7:31 |
You must be logged in to post a reply.
AFT Pharmaceuticals 